Radwan El‐Haggar - Concepedia

Author

Radwan El‐Haggar

Also Known As

EL-Haggar, Radwan, El-Haggar, Radwan, Elhaggar, R., Radwan EL-Haggar, Radwan El-Haggar, Radwan Elhaggar, Radwan El‐Haggar, Radwan S. El-Haggar, Radwan S. Elhaggar, Radwan elhaggar

Publications

837

Citations

H-Index

Concepts

All Affiliations

Helwan University Kafrelsheikh University King Saud University National Research Centre Taif University

About

Radwan El‐Haggar is an author at Helwan University specializing in medicine, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	445
2	Natural Sciences	6	6	318
3	Biochemistry	6	6	318
4	Chemical Biology	2	2	168
5	Biomolecular Engineering	1	1	97

Radwan El‐Haggar

Publications

775

Citations

H-Index

Page 1

	Year	Citations
Novel coumarin-6-sulfonamides as apoptotic anti-proliferative agents: synthesis, <i>in vitro</i> biological evaluation, and QSAR studies Ahmed Sabt, Omaima M. Abdelhafez, Radwan El‐Haggar, Journal of Enzyme Inhibition and Medicinal Chemistry	2018	107
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents Wagdy M. Eldehna, Mahmoud F. Abo-Ashour, Alessio Nocentini, European Journal of Medicinal Chemistry Tail Hydrophobic InteractionsCombinatorial ChemistryMedicinal ChemistryPharmaceutical ChemistryBioorganic Chemistry	2018	98
Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations Wagdy M. Eldehna, Mahmoud A. El Hassab, Mahmoud F. Abo-Ashour, Bioorganic Chemistry Medicinal ChemistryMedicineMolecular Dynamics InvestigationsNovel Cdk2 InhibitorsPharmacological Agent	2021	97
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies Abdulsalam A. M. Alkhaldi, Mohammad M. Al‐Sanea, Alessio Nocentini, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2020	76
Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells Andrea Petreni, Alessandro Bonardi, Carrie L. Lomelino, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryNatural SciencesMedicine5-Fluorouracil Moiety	2020	70
Novel piperazine–chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation Marwa F. Ahmed, Eman Y. Santali, Radwan El‐Haggar Journal of Enzyme Inhibition and Medicinal Chemistry	2020	64
Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, <i>in silico</i> study, and exploratory clinical appraisal Rofida Albash, Maha H. Ragaie, Mahmoud A. El Hassab, Drug Delivery	2022	48
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer Wagdy M. Eldehna, Rofaida Salem, Zainab M. Elsayed, Journal of Enzyme Inhibition and Medicinal Chemistry	2021	39
Anti-Inflammatory Screening and Molecular Modeling of Some Novel Coumarin Derivatives Radwan El‐Haggar, Reem I. Al-Wabli Molecules InflammationMedicinal ChemistryAnti-inflammatoryAnti-inflammatory ScreeningReference Drug	2015	37
Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies Marwa F. Ahmed, Eman Y. Santali, Eman M. Mohi El-Deen, Bioorganic Chemistry Medicinal ChemistryPyridazine DerivativesPotential Egfr InhibitorsMedicineRational Drug Design	2020	30

Page 1